Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination

BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Changes in the microenvironment surrounding oligodendrocyte progenitor cells (OPCs), characterized by excessive production of extracellular matrix (ECM) components driven by elevated TGF-β and CTGF signaling, impair the remyelination capacity of these cells. Decorin (DCN), an endogenous inhibitor of the TGF-β/CTGF signaling axis, has emerged as a potential regulator of ECM homeostasis. METHODS: To improve the therapeutic outcomes of stem cell-based strategies, adipose-derived mesenchymal stem cells (ADMSCs) were preconditioned with metformin (MET) before transplantation into a C57BL/6 mouse model of cuprizone-induced demyelination. Cell viability and the expression of CXCR4 and SDF-1α were evaluated to determine the migratory potential following MET preconditioning. Remyelination and oligodendroglial lineage dynamics were assessed using Luxol Fast Blue (LFB) staining and analysis of MBP and NG2 expression. ECM remodeling and mechanosensitive signaling were evaluated through the expression of DCN, TGF-β, CTGF, and Piezo 1. RESULTS: MET preconditioning was optimized at 1 mmol/L for 24 h based on MTT assay results and increased the migratory potential of ADMSCs, as indicated by upregulation of the CXCR4/SDF-1α axis. Histological analysis revealed enhanced remyelination, accompanied by increased MBP and reduced NG2 expression in treated groups. At the molecular level, transplantation of MET-preconditioned ADMSCs upregulated DCN while downregulating TGF-β, CTGF, and Piezo 1 expression. CONCLUSION: MET preconditioning enhances the therapeutic efficacy of ADMSCs through increasing migration and homing of these cells and consequently promotes remyelination in a cuprizone-induced demyelination model, potentially through DCN-mediated mechanisms.

Authors

Institutions

Publication Details

Journal
Animal Models and Experimental Medicine
Published
2026-11-16
DOI
https://doi.org/10.1002/ame2.70296
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination

Sina Mojaverrostami, Iraj Ragerdi Kashani, Parichehr Pasbakhsh, Ameneh Alikarami et al.
Animal Models and Experimental Medicine
Multiple Sclerosis Research Studies
article

Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination

Sina Mojaverrostami, Iraj Ragerdi Kashani, Parichehr Pasbakhsh, Ameneh Alikarami, Fatemeh Taghizadeh, Golaleh Noorzehi
article en

Abstract

BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Changes in the microenvironment surrounding oligodendrocyte progenitor cells (OPCs), characterized by excessive production of extracellular matrix (ECM) components driven by elevated TGF-β and CTGF signaling, impair the remyelination capacity of these cells. Decorin (DCN), an endogenous inhibitor of the TGF-β/CTGF signaling axis, has emerged as a potential regulator of ECM homeostasis. METHODS: To improve the therapeutic outcomes of stem cell-based strategies, adipose-derived mesenchymal stem cells (ADMSCs) were preconditioned with metformin (MET) before transplantation into a C57BL/6 mouse model of cuprizone-induced demyelination. Cell viability and the expression of CXCR4 and SDF-1α were evaluated to determine the migratory potential following MET preconditioning. Remyelination and oligodendroglial lineage dynamics were assessed using Luxol Fast Blue (LFB) staining and analysis of MBP and NG2 expression. ECM remodeling and mechanosensitive signaling were evaluated through the expression of DCN, TGF-β, CTGF, and Piezo 1. RESULTS: MET preconditioning was optimized at 1 mmol/L for 24 h based on MTT assay results and increased the migratory potential of ADMSCs, as indicated by upregulation of the CXCR4/SDF-1α axis. Histological analysis revealed enhanced remyelination, accompanied by increased MBP and reduced NG2 expression in treated groups. At the molecular level, transplantation of MET-preconditioned ADMSCs upregulated DCN while downregulating TGF-β, CTGF, and Piezo 1 expression. CONCLUSION: MET preconditioning enhances the therapeutic efficacy of ADMSCs through increasing migration and homing of these cells and consequently promotes remyelination in a cuprizone-induced demyelination model, potentially through DCN-mediated mechanisms.

Animal Models and Experimental Medicine
Tehran University of Medical Sciences (IR)
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon